Armata Pharmaceuticals (ARMP) Capital Expenditures Growth (3y) (2016 - 2026)
Armata Pharmaceuticals (ARMP) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Armata Pharmaceuticals |
275.44 Mn |
270.68 Mn |
- |
-68.47% |
| Date | Value |
|---|
| Mar 31, 2026 |
-68.47% |
| Dec 31, 2025 |
28.35% |
| Sep 30, 2025 |
-42.81% |
| Jun 30, 2025 |
-49.19% |
| Mar 31, 2025 |
-25.14% |
| Dec 31, 2024 |
-32.72% |
| Sep 30, 2024 |
-16.40% |
| Jun 30, 2024 |
91.01% |
| Mar 31, 2024 |
-5.69% |
| Dec 31, 2023 |
87.17% |
| Sep 30, 2023 |
251.31% |
| Jun 30, 2023 |
-6.66% |
| Mar 31, 2023 |
168.36% |
| Dec 31, 2022 |
-187.11% |
| Sep 30, 2022 |
179.81% |
| Jun 30, 2022 |
108.13% |
| Mar 31, 2022 |
18.45% |
| Dec 31, 2021 |
-16.46% |
| Sep 30, 2021 |
55.43% |
| Dec 31, 2020 |
172.94% |
